NFE2L2 and colorectal carcinoma: Inhibition of de novo protein synthesis by CHX failed to accelerate Nrf2 degradation in SM-treated CRC cells relative to controls (Fig. S3A, B), which demonstrated that SM downregulates Nrf2 expression primarily through transcriptional suppression rather than enhanced protein degradation.